Question

During 2015, Sheridan Company purchased a building site for its proposed research and development laboratory at a cost of $50,000. Construction of the building was started in 2015. The building was completed on December 31, 2016, at a cost of $360,000 and was placed in service on January 2, 2017. The estimated useful life of the building for depreciation purposes was 20 years. The straight-line method of depreciation was to be employed, and there was no estimated residual value.

Management estimates that about 50% of the projects of the research and development group will result in long-term benefits (i.e., at least 10 years) to the corporation. The remaining projects either benefit the current period or are abandoned before completion. A summary of the number of projects and the direct costs incurred in conjunction with the research and development activities for 2017 appears below.

		Number of Projects		Salaries and Employee Benefits		Other Expenses (excluding Building Depreciation Charges)
Completed projects with long-term benefits		20		$90,000		$51,000
Abandoned projects or projects that
benefit the current period		15		51,000		17,000
Projects in process—results indeterminate		5		39,000		14,000
Total		40		$180,000		$82,000

Upon recommendation of the research and development group, Sheridan Company acquired a patent for manufacturing rights at a cost of $116,000. The patent was acquired on April 1, 2016, and has an economic life of 10 years.

If generally accepted accounting principles were followed, how would the items above relating to research and development activities be reported on the following financial statements?

(a)The company's income statement for 2017.

(b)The company's balance sheet as of December 31, 2017.

Answer 1

	Sheridan Company
a)	Income Statement item & amount for December 31st,2017
*	Research & Development Expenses	$             2,80,000.00
	Less: Amortization of Patent($116000/10)	$                 11,600.00
*	Research & Development Expenses
	Depreciation on Building=($360000/20)	$                 18,000.00
	Salaries & Employees Benefits	$             1,80,000.00
	Other Expenses	$                 82,000.00
	Total Resarch & Development Expenses	$             2,80,000.00
b)	Balance Sheet items & amount for December 31st,2017
	Land	$                 50,000.00
	Building net($360000-($360000/20))	$             3,42,000.00
	Patent (Net of Amortization)=($116000-$20300)	$                 95,700.00
	Patent Amortization in 2016 for 9 months(April to December)	(116000/10)*9/12=	$         8,700.00
	Patent Amortization in 2017 for 12 months(Jan to December)	(116000)/10=	$      11,600.00
	Total of Amortization of Patent		$      20,300.00
	Note:
	The Patent was acquired for manufacturing right so it will be Capitalized as intangible assets & amortized over its useful life.
	All Resarch & Development expenses should be charged as an expense in the year of purchased.